about
Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma.Cost-effectiveness model for hepatitis C screening and treatment: Implications for Egypt and other countries with high prevalence.The influence of time horizon on results of cost-effectiveness analyses.Estimating the Medical Care Costs of Obesity in the United States: Systematic Review, Meta-Analysis, and Empirical Analysis.Association Between the Publication of Clinical Evidence and the Use of Bariatric Surgery.New Metrics for Economic Evaluation in the Presence of Heterogeneity: Focusing on Evaluating Policy Alternatives Rather than Treatment Alternatives.Future Directions for Cost-effectiveness Analyses in Health and MedicineAdherence to the iDSI reference case among published cost-per-DALY averted studiesTaking stock of cost-effectiveness analysis of healthcare in China.Economic Value of Greater Access to Bariatric Procedures for Patients With Severe Obesity and DiabetesSpecialty Drug Coverage Varies Across Commercial Health Plans In The USUse and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY StudiesCost Effectiveness of Nutrition Policies on Processed Meat: Implications for Cancer Burden in the U.S.Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot studyInfluence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World ExperimentTargeted Incentive Programs For Lung Cancer Screening Can Improve Population Health And Economic EfficiencyLeveraging Cumulative Network Meta-analysis and Value of Information Analysis to Understand the Evolving Value of Medical ResearchPreventable Cancer Burden Associated With Poor Diet in the United StatesGrowth and capacity for cost-effectiveness analysis in AfricaAnalyzing the Cost Effectiveness of Policy Responses for COVID-19: The Importance of Capturing Social Consequences
P50
Q34158299-D8F98723-4CCC-46A4-A720-B9D86808333DQ35058571-BC6457E8-2594-4855-A699-B54505F50B5EQ38683936-C48F36D4-847D-40BE-B1BC-13AA64D9EDA6Q38938023-95F2B990-93B7-41F3-8447-C563BB5931B5Q47686239-2761AF59-81A7-4B1A-9062-417795F1180AQ53622322-03FDFCA0-AA74-4D7F-AE75-6BFA80861B41Q57143459-BB48F4C4-7929-40D0-9D08-ACDE3A7D1D07Q64076828-7705E35E-7215-41E2-9F95-405B04D05B27Q64949677-F7049086-6501-4DA3-B80C-C1E8E1A2694AQ88676709-B7C92BDC-63D5-4E76-84A2-E7C3F2DC2D3BQ89473894-9553AE3F-E488-4624-8750-962F24A7E35AQ90042723-A6184497-1823-43F2-8010-96D70729EC24Q90352163-03DBF949-CD8D-46B0-AE31-096C891A8F92Q90379320-91C8DF73-A8C9-4EEC-9786-210BB89B9266Q90830213-4E82FA41-A972-45AA-8978-9880D73DACA0Q90921326-DE943548-CF04-49C2-A2E0-D2E9BE86263CQ91206107-4D520C94-0AA3-4FF6-B610-4AC9B76BF7EEQ92282149-7263FBB7-034C-4E22-A04B-6A50740E1E8CQ94930347-9326B8B5-6AD7-4099-B4BD-6590D04ED0B4Q95309810-A81D3D47-1415-4232-968D-544614FF0E15
P50
description
researcher
@en
հետազոտող
@hy
name
David D Kim
@ast
David D Kim
@en
David D Kim
@es
David D Kim
@nl
type
label
David D Kim
@ast
David D Kim
@en
David D Kim
@es
David D Kim
@nl
prefLabel
David D Kim
@ast
David D Kim
@en
David D Kim
@es
David D Kim
@nl
P106
P1153
57194267155
P21
P31
P496
0000-0002-3383-8972